Office of the Vice President for Research
HUMAN SUBJECTS OFFICE
Senior / Clinical Trials.gov Compliance Specialist (Multiple levels)
This Professional and Scientific position will be filled as either a Clinical Trials.gov Compliance Specialist (PRC1) or Senior Clinical Trials.gov Compliance Specialist (PRC2). Please indicate in your cover letter, which position you want to be considered for, or you can indicate both.
The Human Subjects Office, at the University of Iowa is seeking a Clinical Trials.gov Compliance Specialist (PRC1) or Senior Clinical Trials.gov Compliance Specialist (PRC2). This position will act as education and compliance expert with regard to ClinicalTrials.gov, federal regulations, Institutional Review Board (IRB) requirements, and University of Iowa policies and procedures for the protection of human subjects involved in research. They will develop and coordinate procedures and programs to enhance investigator understanding and compliance with ClinicalTrials.gov, the HawkIRB application process, and Institutional Review Board (IRB) policies and procedures.
Occasional in-state and out-of-state travel is required to attend conferences and meetings.
For more information, please see: https://research.uiowa.edu/office-vice-president-research/open-positions
To apply: See requisition 22005601 at https://jobs.uiowa.edu
Applicable background checks will be conducted
The University of Iowa is an equal opportunity/affirmative action employer. All qualified applicants are encouraged to apply and will receive consideration for employment free from discrimination on the basis of race, creed, color, religion, national origin, age, sex, pregnancy (including childbirth and related conditions), disability, genetic information, status as a U.S. veteran, service in the U.S. military, sexual orientation, gender identity, or associational preferences.
Advertising started November 2, 2022 and will run through November 16, 2022.
Reminder: Once the advertising window has closed all opportunities to apply for the position end, and no additional applications can be considered.
